Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GABRIEL NOAH MANNIS

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1881929347
CMS profile
1306768
Location
STANFORD, CA

General Payments · PY2018–2024

$164,020.99

  • Reported across 170 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$28,968.55

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $24,325.00 8
Travel and Lodging $3,342.05 12
Food and Beverage $1,301.50 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Daiichi Sankyo Inc. $8,799.73 10
Stemline Therapeutics Inc. $8,529.69 7
ABBVIE INC. $6,897.53 12
SERVIER PHARMACEUTICALS LLC $3,724.29 5
Aadi Bioscience, Inc. $750.00 1
TAIHO ONCOLOGY, INC. $267.31 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $22,252.65 31
PY2019 $15,239.87 27
PY2020 $32,686.69 20
PY2021 $21,476.73 17
PY2022 $26,170.65 20
PY2023 $17,225.85 19
PY2024 $28,968.55 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Aadi Bioscience, Inc. $750.00 08/28/2024 Consulting Fee Undisputed 01/23/2026 1119596867 CMS
ABBVIE INC. $55.94 01/11/2024 Food and Beverage Undisputed 01/23/2026 1104959701 CMS
ABBVIE INC. $125.56 01/31/2024 Food and Beverage Undisputed 01/23/2026 1104959703 CMS
ABBVIE INC. $247.47 01/31/2024 Travel and Lodging Undisputed 01/23/2026 1104959705 CMS
ABBVIE INC. $103.62 01/31/2024 Travel and Lodging Undisputed 01/23/2026 1104959707 CMS
ABBVIE INC. $37.93 02/01/2024 Food and Beverage Undisputed 01/23/2026 1104959709 CMS
ABBVIE INC. $6.98 02/01/2024 Food and Beverage Undisputed 01/23/2026 1104959711 CMS
ABBVIE INC. $81.05 02/01/2024 Travel and Lodging Undisputed 01/23/2026 1104959713 CMS
ABBVIE INC. $160.92 02/01/2024 Travel and Lodging Undisputed 01/23/2026 1104959715 CMS
ABBVIE INC. $5,750.00 03/29/2024 Consulting Fee Undisputed 01/23/2026 1104959717 CMS
ABBVIE INC. $30.44 12/05/2024 Food and Beverage Undisputed 01/23/2026 1104959719 CMS
ABBVIE INC. $147.91 12/05/2024 Food and Beverage Undisputed 01/23/2026 1104959721 CMS
ABBVIE INC. $149.71 12/07/2024 Food and Beverage Undisputed 01/23/2026 1104959723 CMS
Daiichi Sankyo Inc. $595.24 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1089452186 CMS
Daiichi Sankyo Inc. $253.47 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1089452188 CMS
Daiichi Sankyo Inc. $336.75 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1089452190 CMS
Daiichi Sankyo Inc. $103.92 04/18/2024 Food and Beverage Undisputed 01/23/2026 1089452192 CMS
Daiichi Sankyo Inc. $131.93 04/19/2024 Food and Beverage Undisputed 01/23/2026 1089452184 CMS
Daiichi Sankyo Inc. $60.89 04/19/2024 Food and Beverage Undisputed 01/23/2026 1089452194 CMS
Daiichi Sankyo Inc. $39.92 04/19/2024 Food and Beverage Undisputed 01/23/2026 1089452196 CMS
Daiichi Sankyo Inc. $182.61 04/20/2024 Travel and Lodging Undisputed 01/23/2026 1089452198 CMS
Daiichi Sankyo Inc. $3,547.50 05/15/2024 Consulting Fee Undisputed 01/23/2026 1089452202 CMS
Daiichi Sankyo Inc. $3,547.50 06/12/2024 Consulting Fee Undisputed 01/23/2026 1089452200 CMS
SERVIER PHARMACEUTICALS LLC $2,800.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1147259682 CMS
SERVIER PHARMACEUTICALS LLC $368.94 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1147259684 CMS
SERVIER PHARMACEUTICALS LLC $136.05 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1147259686 CMS
SERVIER PHARMACEUTICALS LLC $383.13 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1147259688 CMS
SERVIER PHARMACEUTICALS LLC $36.17 11/15/2024 Food and Beverage Undisputed 01/23/2026 1147259690 CMS
Stemline Therapeutics Inc. $59.18 01/30/2024 Food and Beverage Undisputed 01/23/2026 1142959973 CMS
Stemline Therapeutics Inc. $492.80 01/31/2024 Travel and Lodging Undisputed 01/23/2026 1142959969 CMS
Stemline Therapeutics Inc. $2,590.00 01/31/2024 Consulting Fee Undisputed 01/23/2026 1142959971 CMS
Stemline Therapeutics Inc. $2,220.00 06/14/2024 Consulting Fee Undisputed 01/23/2026 1142959975 CMS
Stemline Therapeutics Inc. $30.66 06/14/2024 Food and Beverage Undisputed 01/23/2026 1142959977 CMS
Stemline Therapeutics Inc. $3,120.00 08/06/2024 Consulting Fee Undisputed 01/23/2026 1142959979 CMS
Stemline Therapeutics Inc. $17.05 12/09/2024 Food and Beverage Undisputed 01/23/2026 1142959981 CMS
TAIHO ONCOLOGY, INC. $267.31 12/06/2024 Food and Beverage Undisputed 01/23/2026 1137943815 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.